State Street Corp Has $5.33 Billion Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

State Street Corp grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 209.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 14,834,746 shares of the medical equipment provider’s stock after purchasing an additional 10,040,407 shares during the quarter. State Street Corp owned about 4.15% of Intuitive Surgical worth $5,330,124,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Hexagon Capital Partners LLC raised its position in Intuitive Surgical by 200.0% in the 4th quarter. Hexagon Capital Partners LLC now owns 69 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 46 shares during the last quarter. Paragon Capital Management Ltd bought a new stake in Intuitive Surgical during the 4th quarter worth about $26,000. Hanseatic Management Services Inc. lifted its position in Intuitive Surgical by 200.0% during the 4th quarter. Hanseatic Management Services Inc. now owns 72 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 48 shares in the last quarter. Wolff Wiese Magana LLC raised its holdings in shares of Intuitive Surgical by 1,000.0% in the 4th quarter. Wolff Wiese Magana LLC now owns 77 shares of the medical equipment provider’s stock valued at $28,000 after purchasing an additional 70 shares during the period. Finally, Sargent Bickham Lagudis LLC raised its holdings in shares of Intuitive Surgical by 200.0% in the 4th quarter. Sargent Bickham Lagudis LLC now owns 78 shares of the medical equipment provider’s stock valued at $28,000 after purchasing an additional 52 shares during the period. 83.69% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical stock traded up $4.51 during trading hours on Friday, reaching $227.81. The stock had a trading volume of 71,275 shares, compared to its average volume of 2,181,973. The company has a market cap of $81.77 billion, a price-to-earnings ratio of 50.70, a PEG ratio of 4.98 and a beta of 1.26. The business’s 50 day moving average price is $259.07 and its 200-day moving average price is $295.24. Intuitive Surgical, Inc. has a 52 week low of $206.60 and a 52 week high of $369.69.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last issued its quarterly earnings results on Thursday, April 21st. The medical equipment provider reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.07. The company had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.43 billion. Intuitive Surgical had a net margin of 27.84% and a return on equity of 14.16%. Intuitive Surgical’s quarterly revenue was up 15.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.17 EPS. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 4.14 earnings per share for the current fiscal year.

ISRG has been the topic of a number of research reports. TheStreet lowered shares of Intuitive Surgical from a “b-” rating to a “c+” rating in a research note on Thursday, May 19th. Bank of America initiated coverage on shares of Intuitive Surgical in a research report on Tuesday, March 1st. They set a “buy” rating on the stock. Wolfe Research assumed coverage on shares of Intuitive Surgical in a research note on Tuesday, April 5th. They issued a “peer perform” rating and a $315.00 price objective for the company. UBS Group upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $317.00 to $325.00 in a research report on Wednesday, February 2nd. Finally, Citigroup decreased their price objective on shares of Intuitive Surgical from $360.00 to $305.00 in a research report on Tuesday, May 17th. Eight research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $323.70.

In other Intuitive Surgical news, EVP Myriam Curet sold 6,000 shares of the firm’s stock in a transaction on Tuesday, April 26th. The stock was sold at an average price of $252.51, for a total value of $1,515,060.00. Following the transaction, the executive vice president now owns 361 shares in the company, valued at approximately $91,156.11. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile (Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More